EMT involves a variety of signaling pathways, including transforming growth factor β (TGF-β), Wnt/β-catenin, etc. Activation of the Wnt/ beta-catenin pathway has been shown to be an important regulator of EMT in many different types of cancer [14]. This evidence concerns the gene CTNNB1 and cancer.